인쇄하기
취소
|
The era to manage diabetes with a single dose a week is now coming.
According to the industry concerned on the 11th, each of 4 multinational pharmaceutical companies have currently succeeded developing 2 types of long-acting diabetes treatments. Those products are expected to acquire approvals in Korea.
DPP-4 inhibitor type products that are most popularare also a part of them.
Development c...